T. Jackson

A phase I clinical trial of a ribozyme-based angiogenesis inhibitor targeting vascular endothelial growth factor receptor-1 for patients with refractory solid tumors

E. Borden, J. Cowens, R. Ganapathi, 2005, Molecular Cancer Therapeutics.

Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial

Alimuddin Zumla, J. Darbyshire, G. Rook, 1999, The Lancet.